North American Lymphoma Analysis & Statistics

20 results
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19 New
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19 The North America Radiopharmaceuticals Ma…

  • North America
  • Diagnostics
  • Marketing Research
  • Industry analysis
Global Lymphoma Therapeutics Industry New
Global Lymphoma Therapeutics Industry

Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-…

  • World
  • China
  • Lymphoma
  • Industry analysis
Peripheral T cell Lymphoma - Epidemiology Forecast - 2032
Peripheral T cell Lymphoma - Epidemiology Forecast - 2032

" Peripheral T-cell Lymphoma - Epidemiology Forecast– 2032” report delivers an in-depth understanding of the PTCL, historical and forecasted epidemiology as well as the PTCL market trends in the Unite…

  • Japan
  • United States
  • Lymphoma
  • Industry analysis
  • Stem Cell Transplantation
  • Health Expenditure
Rituximab Biosimilars Global Market Report 2022
Rituximab Biosimilars Global Market Report 2022

Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life …

  • United States
  • Monoclonal Antibody
  • Lymphoma
  • Industry analysis
Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022
Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022

“Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the p…

  • Poland
  • World
  • Lymphoma
  • Industry analysis
T-Cell Lymphoma Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)
T-Cell Lymphoma Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

The Global T-Cell Lymphoma Market was valued at USD 1,547.04 million in 2020, and it is expected to reach USD 2509.94 million by 2026, registering a CAGR of 8.25% during the period of 2021-2026. Due …

  • APAC
  • Europe
  • Lymphoma
  • Industry analysis
  • Health Expenditure
  • Stem Cell Transplantation
Global Non-Hodgkin Lymphoma Therapeutics Industry
Global Non-Hodgkin Lymphoma Therapeutics Industry

Abstract: - Global Non-Hodgkin Lymphoma Therapeutics Market to Reach $8.1 Billion  by 2027 - Amid the COVID-19 crisis, the global market for Non-Hodgkin Lymphoma Therapeutics estimated at US$5.4 Bil…

  • World
  • China
  • Lymphoma
  • Therapy
  • Industry analysis
Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change

Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life …

  • World
  • United States
  • Lymphoma
  • Monoclonal Antibody
  • Industry analysis
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2032
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2032

" Peripheral T-cell Lymphoma - Market Insights, Epidemiology and Market Forecast– 2032” report delivers an in-depth understanding of the PTCL, historical and forecasted epidemiology as well as the PTC…

  • Japan
  • United States
  • Therapy
  • Lymphoma
  • Industry analysis
  • Stem Cell Transplantation
  • Drug Approval
Non-Hodgkin Lymphoma Treatment Market Research Report by Treatment, Cell Type, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 New
Non-Hodgkin Lymphoma Treatment Market Research Report by Treatment, Cell Type, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Non-Hodgkin Lymphoma Treatment Market Research Report by Treatment, Cell Type, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 The United States Non-Hodgkin Lymphoma Treatment …

  • United States
  • Lymphoma
  • Industry analysis
Hemato Oncology Testing Market Research Report by Products & Services, Cancer, Technology, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 New
Hemato Oncology Testing Market Research Report by Products & Services, Cancer, Technology, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Hemato Oncology Testing Market Research Report by Products & Services, Cancer, Technology, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 The United States Hemato On…

  • United States
  • Marketing Research
  • Research And Development
  • Industry analysis
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 New
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 The United States Radiopharmaceuticals Mark…

  • United States
  • Diagnostics
  • Marketing Research
  • Industry analysis
Lymphoma Therapeutics Market Research Report by Treatment, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 New
Lymphoma Therapeutics Market Research Report by Treatment, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Lymphoma Therapeutics Market Research Report by Treatment, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 The United States Lymphoma Therapeutics Market size was est…

  • United States
  • Lymphoma
  • Industry analysis
Photopheresis Product Market Research Report by Product, Therapeutic Area, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 New
Photopheresis Product Market Research Report by Product, Therapeutic Area, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Photopheresis Product Market Research Report by Product, Therapeutic Area, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 The United States Photopheresis Product Mar…

  • United States
  • Transplantation
  • Marketing Research
  • Industry analysis
North America Radiotherapy Market Size, Share & Industry Trends Analysis Report By End User, By Type, By Country and Growth Forecast, 2022 - 2028
North America Radiotherapy Market Size, Share & Industry Trends Analysis Report By End User, By Type, By Country and Growth Forecast, 2022 - 2028

The North America Radiotherapy Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028). Radiation therapy could be the only option for some patients. However, radiation…

  • North America
  • United States
  • Cancer
  • Oncology
  • Industry analysis
2021 Canada Hematology and Flow Cytometry Database and Analysis
2021 Canada Hematology and Flow Cytometry Database and Analysis

2021 Canada Hematology and Flow Cytometry Database and Analysis: Analyzers and Reagents, Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Techno…

  • Canada
  • Molecular Diagnostics
  • In Vitro Diagnostic Reagent
  • Industry analysis
2021 Mexico Hematology and Flow Cytometry Database and Analysis
2021 Mexico Hematology and Flow Cytometry Database and Analysis

2021 Mexico Hematology and Flow Cytometry Database and Analysis: Analyzers and Reagents, Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Techno…

  • Mexico
  • Molecular Diagnostics
  • In Vitro Diagnostic Reagent
  • Industry analysis
Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL), Pharma Intelligence
Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL), Pharma Intelligence

This Market Spotlight report covers the Cutaneous T-Cell Lymphoma (CTCL) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst …

  • World
  • Europe
  • Clinical Trial
  • Lymphoma
  • Industry analysis
Diffuse Large B-Cell Lymphoma (DLBCL) KOL Interview – US
Diffuse Large B-Cell Lymphoma (DLBCL) KOL Interview – US

Overview A US-based key opinion leader (KOL) gives insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for DLBCL. Therapies discussed include Polivy, Monjuvi, Zyn…

  • United States
  • Lymphoma
  • Industry analysis
Follicular Lymphoma KOL Interview – US
Follicular Lymphoma KOL Interview – US

Overview This interview with a US-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for follicular lymphoma. Disease stra…

  • United States
  • Lymphoma
  • Industry analysis